These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A Phase IIIb study to evaluate the safety of ranibizumab in subjects with neovascular age-related macular degeneration. Boyer DS; Heier JS; Brown DM; Francom SF; Ianchulev T; Rubio RG Ophthalmology; 2009 Sep; 116(9):1731-9. PubMed ID: 19643495 [TBL] [Abstract][Full Text] [Related]
3. Randomized, double-masked, sham-controlled trial of ranibizumab for neovascular age-related macular degeneration: PIER Study year 1. Regillo CD; Brown DM; Abraham P; Yue H; Ianchulev T; Schneider S; Shams N Am J Ophthalmol; 2008 Feb; 145(2):239-248. PubMed ID: 18222192 [TBL] [Abstract][Full Text] [Related]
4. Safety and pharmacokinetics of intravitreal 2-methoxyestradiol implants in normal rabbit and pharmacodynamics in a rat model of choroidal neovascularization. Robinson MR; Baffi J; Yuan P; Sung C; Byrnes G; Cox TA; Csaky KG Exp Eye Res; 2002 Feb; 74(2):309-17. PubMed ID: 11950241 [TBL] [Abstract][Full Text] [Related]
5. A 1-year retrospective review of ranibizumab for naive nonsubfoveal choroidal neovascularization secondary to age-related macular degeneration. Arias L; Ruiz-Moreno JM; Gómez-Ulla F; Fernández M; Montero J Retina; 2009; 29(10):1444-9. PubMed ID: 19730163 [TBL] [Abstract][Full Text] [Related]
6. Antiangiogenic effect of oral 2-methoxyestradiol on choroidal neovascularization in mice. Funakoshi T; Birsner AE; D'Amato RJ Exp Eye Res; 2006 Nov; 83(5):1102-7. PubMed ID: 16828472 [TBL] [Abstract][Full Text] [Related]
8. Subgroup analysis of the MARINA study of ranibizumab in neovascular age-related macular degeneration. Boyer DS; Antoszyk AN; Awh CC; Bhisitkul RB; Shapiro H; Acharya NR; Ophthalmology; 2007 Feb; 114(2):246-52. PubMed ID: 17270674 [TBL] [Abstract][Full Text] [Related]
9. Effects on choroidal neovascularization after anti-VEGF Upload using intravitreal ranibizumab, as determined by spectral domain-optical coherence tomography. Framme C; Panagakis G; Birngruber R Invest Ophthalmol Vis Sci; 2010 Mar; 51(3):1671-6. PubMed ID: 19875667 [TBL] [Abstract][Full Text] [Related]
10. [Present status of studies on the treatment of choroidal neovascularization by Anecortave acetate]. Li X; Wang YS Zhonghua Yan Ke Za Zhi; 2008 Jun; 44(6):571-4. PubMed ID: 19035252 [TBL] [Abstract][Full Text] [Related]
11. [Be cautious to treat choroidal neovascularization with anti-angiogenesis pharmacotherapy]. Wei WB; Mo J Zhonghua Yan Ke Za Zhi; 2008 Mar; 44(3):193-5. PubMed ID: 18785539 [TBL] [Abstract][Full Text] [Related]
12. Tetrathiomolybdate as an antiangiogenesis therapy for subfoveal choroidal neovascularization secondary to age-related macular degeneration. Vine AK; Brewer GJ Trans Am Ophthalmol Soc; 2002; 100():73-6; discussion 76-7. PubMed ID: 12545680 [TBL] [Abstract][Full Text] [Related]
13. Photodynamic therapy with intravitreal application of triamcinolone acetonide in age-related macular degeneration: functional results in 54 patients. Frimpong-Boateng A; Bunse A; Rüfer F; Roider J Acta Ophthalmol; 2009 Mar; 87(2):183-7. PubMed ID: 18547278 [TBL] [Abstract][Full Text] [Related]
15. Randomized, double-masked, sham-controlled trial of ranibizumab for neovascular age-related macular degeneration: PIER study year 2. Abraham P; Yue H; Wilson L Am J Ophthalmol; 2010 Sep; 150(3):315-324.e1. PubMed ID: 20598667 [TBL] [Abstract][Full Text] [Related]